List of Tables
Table 1. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood
Table 3. Key Players of Urine
Table 4. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cytomegalovirus (CMV) Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cytomegalovirus (CMV) Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region (2020-2025)
Table 8. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region (2026-2031)
Table 10. Cytomegalovirus (CMV) Diagnostic Market Trends
Table 11. Cytomegalovirus (CMV) Diagnostic Market Drivers
Table 12. Cytomegalovirus (CMV) Diagnostic Market Challenges
Table 13. Cytomegalovirus (CMV) Diagnostic Market Restraints
Table 14. Global Cytomegalovirus (CMV) Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cytomegalovirus (CMV) Diagnostic Market Share by Players (2020-2025)
Table 16. Global Top Cytomegalovirus (CMV) Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Diagnostic as of 2024)
Table 17. Ranking of Global Top Cytomegalovirus (CMV) Diagnostic Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cytomegalovirus (CMV) Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Headquarters and Area Served
Table 20. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Product and Application
Table 21. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cytomegalovirus (CMV) Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Type (2020-2025)
Table 25. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Type (2026-2031)
Table 27. Global Cytomegalovirus (CMV) Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Application (2020-2025)
Table 29. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Application (2026-2031)
Table 31. North America Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Laboratories Company Details
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Cytomegalovirus (CMV) Diagnostic Product
Table 49. Abbott Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. bioMérieux Company Details
Table 52. bioMérieux Business Overview
Table 53. bioMérieux Cytomegalovirus (CMV) Diagnostic Product
Table 54. bioMérieux Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 55. bioMérieux Recent Development
Table 56. BD Biosciences Company Details
Table 57. BD Biosciences Business Overview
Table 58. BD Biosciences Cytomegalovirus (CMV) Diagnostic Product
Table 59. BD Biosciences Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 60. BD Biosciences Recent Development
Table 61. Bio-Rad Laboratories Company Details
Table 62. Bio-Rad Laboratories Business Overview
Table 63. Bio-Rad Laboratories Cytomegalovirus (CMV) Diagnostic Product
Table 64. Bio-Rad Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 65. Bio-Rad Laboratories Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Cytomegalovirus (CMV) Diagnostic Product
Table 69. Roche Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Bioneer Corp Company Details
Table 72. Bioneer Corp Business Overview
Table 73. Bioneer Corp Cytomegalovirus (CMV) Diagnostic Product
Table 74. Bioneer Corp Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 75. Bioneer Corp Recent Development
Table 76. Siemens Healthcare Company Details
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare Cytomegalovirus (CMV) Diagnostic Product
Table 79. Siemens Healthcare Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Cytomegalovirus (CMV) Diagnostic Product
Table 84. Thermo Fisher Scientific Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Realstar Group Company Details
Table 87. Realstar Group Business Overview
Table 88. Realstar Group Cytomegalovirus (CMV) Diagnostic Product
Table 89. Realstar Group Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 90. Realstar Group Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Cytomegalovirus (CMV) Diagnostic Product
Table 94. Merck Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Qiagen Company Details
Table 97. Qiagen Business Overview
Table 98. Qiagen Cytomegalovirus (CMV) Diagnostic Product
Table 99. Qiagen Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 100. Qiagen Recent Development
Table 101. Guangdong Hybribio Company Details
Table 102. Guangdong Hybribio Business Overview
Table 103. Guangdong Hybribio Cytomegalovirus (CMV) Diagnostic Product
Table 104. Guangdong Hybribio Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 105. Guangdong Hybribio Recent Development
Table 106. Sansure Biotech Company Details
Table 107. Sansure Biotech Business Overview
Table 108. Sansure Biotech Cytomegalovirus (CMV) Diagnostic Product
Table 109. Sansure Biotech Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
Table 110. Sansure Biotech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Cytomegalovirus (CMV) Diagnostic Picture
Figure 2. Global Cytomegalovirus (CMV) Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cytomegalovirus (CMV) Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Blood Features
Figure 5. Urine Features
Figure 6. Global Cytomegalovirus (CMV) Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cytomegalovirus (CMV) Diagnostic Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Centers and Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Cytomegalovirus (CMV) Diagnostic Report Years Considered
Figure 12. Global Cytomegalovirus (CMV) Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cytomegalovirus (CMV) Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region: 2024 VS 2031
Figure 15. Global Cytomegalovirus (CMV) Diagnostic Market Share by Players in 2024
Figure 16. Global Top Cytomegalovirus (CMV) Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Diagnostic as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cytomegalovirus (CMV) Diagnostic Revenue in 2024
Figure 18. North America Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
Figure 20. United States Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
Figure 24. Germany Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Share by Region (2020-2031)
Figure 32. China Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
Figure 40. Mexico Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
Figure 44. Turkey Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 48. bioMérieux Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 49. BD Biosciences Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 52. Bioneer Corp Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 53. Siemens Healthcare Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 55. Realstar Group Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 56. Merck Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 57. Qiagen Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 58. Guangdong Hybribio Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 59. Sansure Biotech Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed